BENGALURU, Oct 31 (Reuters) - India's Mankind Pharma MNKI.NS posted an over 19% rise in second-quarter profit on Tuesday, propelled by strong domestic sales and steady growth in the company's chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results